Background and Objectives: Acute uncomplicated cystitis (AC) is common among women. Acute onset of specific typical symptoms may serve as reliable criteria for developing a cost-effective strategy to make an accurate diagnosis of AC. We aimed to evaluate the diagnostic values of most common symptoms and signs of AC depending on their presence and severity. Methods: The current trial was designed as a case-control study. Data derived from the Acute Cystitis Symptom Score (ACSS) database were analyzed. Diagnostic values of the symptoms and their severity were assessed via the calculations of the sensitivity and specificity, odds ratio, positive and negative likelihood ratios. The strength of associations was estimated by the coefficient of correlation (Pearson’s R). Results: Data from 819 female subjects (423 Patients, 396 controls) with the mean age of 37.1 ± 15.3 were analyzed. Highest diagnostic values for AC in this study belonged to dysuria, urgency, and frequency. Interestingly, complaints of vaginal discharge was not found to decrease the odds for having AC in the study population. Conclusions: The severity of the symptom is even more essential than just its presence for an accurate diagnosis. The ACSS is an accurate tool and may be recommended for clinical practice and studies for diagnosis of AC in women. Further studies and unification of terms are need.

Keywords:
Urinary tract infection, Cystitis, Female, Acute uncomplicated cystitis, Symptoms and signs, Questionnaires, Diagnostic value, Symptom score, Case-control study
1.
Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, et al: A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996; 335: 468–474.
2.
Bonkat G, Pickard R, Bartoletti R, Bruyère F, Greelings SE, Wagenlehner FME, et al: EAU Guidelines on Urological Infections; in: EAU Guidelines. Edn. presented at the EAU Annual Congress London. European Association of Urology, 2017. http://uroweb.org/wp-content/uploads/19-Urological-infections_2017_web.pdf.
3.
Grigoryan L, Trautner BW, Gupta K: Diagnosis and management of urinary tract infections in the outpatient setting. JAMA 2014; 312: 1677.
4.
Frazee BW, Enriquez K, Ng V, Alter H: Abnormal urinalysis results are common, regardless of specimen collection technique, in women without urinary tract infections. J Emerg Med 2015; 48: 706–711.
5.
Stamm WE, Hooton TM: Management of urinary tract infections in adults. N Engl J Med 1993; 329: 1328–1334.
6.
Kranz J, Schmidt S, Lebert C, Schneidewind L, Mandraka F, Kunze M, et al: The 2017 Update of the German Clinical guideline on epidemiology, diagnostics, therapy, prevention, and management of uncomplicated urinary tract infections in adult patients: part 1. Urol Int 2018; 100: 263–270.
7.
Gupta K, Hooton TM, Roberts PL, Stamm WE: Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med 2001; 135: 9–16.
8.
Heytens S, De Sutter A, De Backer D, Verschraegen G, Christiaens T: Cystitis: symptomatology in women with suspected uncomplicated urinary tract infection. J Women’s Health 2011; 20: 1117–1121.
9.
Bremnor JD, Sadovsky R: Evaluation of dysuria in adults. Am Fam Physician 2002; 65: 1589–1596.
10.
Berg E, Benson DM, Haraszkiewicz P, Grieb J, McDonald J: High prevalence of sexually transmitted diseases in women with urinary infections. Acad Emerg Med 1996; 3: 1030–1034.
11.
Foxman B, Somsel P, Tallman P, Gillespie B, Raz R, Colodner R, et al: Urinary tract infection among women aged 40 to 65: behavioral and sexual risk factors. J Clin Epidemiol 2001; 54: 710–718.
12.
Wagenlehner FM, Weidner W, Pilatz A, Naber KG: Urinary tract infections and bacterial prostatitis in men. Curr Opin Infect Dis 2014; 27: 97–101.
13.
Bollestad M, Grude N, Lindbaek M: A randomized controlled trial of a diagnostic algorithm for symptoms of uncomplicated cystitis at an out-of-hours service. Scand J Prim Health Care 2015; 33: 57–64.
14.
Little P, Turner S, Rumsby K, Warner G, Moore M, Lowes J, et al: Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess (Rockv) 2009; 13:iii-iv, ix-xi, 1–73.
15.
Bent S, Saint S: The optimal use of diagnostic testing in women with acute uncomplicated cystitis. Dis Mon 2003; 49: 83–98.
16.
Saint S, Scholes D, Fihn SD, Farrell RG, Stamm WE: The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in women. Am J Med 1999; 106: 636–641.
17.
Alidjanov JF, Alidjanova OT, Pilatz A, Naber KG, Wagenlehner FM: Certificate of Authorship: “Acute Cystitis Symptom Score (ACSS)” 2015. http://inter.interoco.com/copyright-depository/work-of-science/1013-1951954939.html.
18.
Alidjanov JF: Author’s certificate #2463: “Acute Cystitis Symptom Score (ACSS)” 2015. http://www.avtor-depository.com/index.php?option=com_desposition&task=display_desp_det&id=2612&lang=ru.
19.
Alidjanov JF, Abdufattaev UA, Makhsudov SA, Pilatz A, Akilov FA, Naber KG, et al: New self-reporting questionnaire to assess urinary tract infections and differential diagnosis: acute cystitis symptom score. Urol Int 2014; 92: 230–236.
20.
Alidjanov JF, Naber KG, Abdufattaev UA, Pilatz A, Wagenlehner FM: Reevaluation of the acute cystitis symptom score, a self-reporting questionnaire. Part I. development, diagnosis and differential diagnosis. Antibiotics 2018; 7.
21.
Alidjanov JF, Abdufattaev UA, Makhsudov SA, Pilatz A, Akilov FA, Naber KG, et al: The acute cystitis symptom score for patient-reported outcome assessment. Urol Int 2016; 97: 402–409.
22.
Alidjanov J, Naber K, Abdufattaev UA, Pilatz A, Wagenlehner FM, Alidjanov JF, et al: Reevaluation of the acute cystitis symptom score, a self-reporting questionnaire. Part II. Patient-reported outcome assessment. Antibiotics 2018; 7: 43.
23.
Alidjanov JF, Abdufattaev UA, Makhmudov DK, Mirkhamidov DK, Khadzhikhanov FA, Azgamov AV, et al: [Development and clinical testing of the russian version of the acute cystitis symptom score – ACSS]. Urologiia 2014; 6: 14–22.
24.
Alidjanov JF, Pilatz A, Abdufattaev UA, Wiltink J, Weidner W, Naber KG, et al: [German validation of the acute cystitis symptom score]. Urologe 2015; 54: 1269–1276.
25.
Alidjanov JF, Pilatz A, Abdufattaev UA, Wiltink J, Weidner W, Naber KG, et al: Neuer Fragebogen zur deutschen Validierung des “acute cystitis symptom score.” Urologe 2017; 56: 364–366.
26.
Magyar A, Alidjanov J, Pilatz A, Nagy K, Arthanareeswaran VKA, Póth S, et al: The role of the Acute Cystitis Symptom Score questionnaire for research and antimicrobial stewardship. Validation of the Hungarian version. Cent Eur J Urol 2018; 71: 134–141.
27.
Alidjanov JF, Alidjanova OT, Basitkhanov BT, Abdufattaev UA, Pilatz A, Naber KG, et al: Certificate of Authorship: “e-USQOLAT: The Web-Based Online Platform for Diagnosis of Lower Urinary Tract Infections in Women” 2017. http://inter.interoco.com/copyright-depository/computer-programs/1438-2017-05-18-10-59-16.html?path=computer-programs.
28.
R Core Team: R: A Language and Environment for Statistical Computing 2017. https://www.r-project.org/.
29.
Stevenson M with contributions from TN, Heuer C, Marshall J, Sanchez J, Thornton R, Reiczigel J, et al: epir: Tools for the Analysis of Epidemiological Data 2017. https://cran.r-project.org/package=epiR.
30.
Schwarzer G: Meta: an R package for meta-analysis. R News 2007; 7: 40–45.
31.
Johansen TEB, Botto H, Cek M, Grabe M, Tenke P, Wagenlehner FME, et al: Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. Int J Antimicrob Agents 2011; 38: 64–70.
32.
Mond N, Percival A, Williams J, Brumfitt W: Presentation, diagnosis, and treatment of urinary-tract infections in general practice. Lancet (London, England) 1965; 1: 514–516.
33.
Dobbs FF, Fleming DM: A simple scoring system for evaluating symptoms, history and urine dipstick testing in the diagnosis of urinary tract infection. J R Coll Gen Pract 1987; 37: 100–104.
34.
Baerheim A, Digranes A, Jureen R, Malterud K: Generalized symptoms in adult women with acute uncomplicated lower urinary tract infection: an observational study. MedGenMed 2003; 5: 1.
35.
Mishra B, Srivastava S, Singh K, Pandey A, Agarwal J: Symptom-based diagnosis of urinary tract infection in women: are we over-prescribing antibiotics? Int J Clin Pract 2012; 66: 493–498.
36.
Dans PE, Klaus B: Dysuria in women. Johns Hopkins Med J 1976; 138: 13–18.
37.
Komaroff AL, Pass TM, McCue JD, Cohen AB, Hendricks TM, Friedland G: Management strategies for urinary and vaginal infections. Arch Intern Med 1978; 138: 1069–1073.
38.
Wong ES, Fennell CL, Stamm WE: Urinary tract infection among women attending a clinic for sexually transmitted diseases. Sex Transm Dis 1984; 11: 18–23.
39.
Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S: Does this woman have an acute uncomplicated urinary tract infection? JAMA 2002; 287: 2701–2710.
40.
McSherry J: Frequency/dysuria syndrome in young women. Can Fam Physician 1988; 34: 1891–1894.
41.
Shapiro T, Dalton M, Hammock J, Lavery R, Matjucha J, Salo DF: The prevalence of urinary tract infections and sexually transmitted disease in women with symptoms of a simple urinary tract infection stratified by low colony count criteria. Acad Emerg Med 2005; 12: 38–44.
42.
Giesen LG, Cousins G, Dimitrov BD, van de Laar FA, Fahey T: Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs. BMC Fam Pr 2010; 11: 78.
43.
Barry HC, Ebell MH, Hickner J: Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies. J Fam Pract 1997; 44: 49–60.
44.
Holm A, Cordoba G, Siersma V, Brodersen J: Development and validation of a condition-specific diary to measure severity, bothersomeness and impact on daily activities for patients with acute urinary tract infection in primary care. Health Qual Life Outcomes 2017; 15: 57.
45.
Clayson D, Wild D, Doll H, Keating K, Gondek K: Validation of a patient-administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): the UTI Symptom Assessment questionnaire. BJU Int 2005; 96: 350–359.
46.
Cai T, Mazzoli S, Migno S, Malossini G, Lanzafame P, Mereu L, et al: Development and validation of a nomogram predicting recurrence risk in women with symptomatic urinary tract infection. Int J Urol 2014; 21: 929–934.
47.
Akilov FA, Aroustamov DL, Alidjanov JF, Rakhmonov OM, Salimov ID: [Development Of Uzbek And Russian Versions Of Urinary Tract Infections Symptom Assessment (UTISA)]; in: Urinary Tract Infections Symptom Assessment (UTISA). Almaty, 2010, pp 125–126.
48.
Schiavi MC, Di Pinto A, Sciuga V, Faiano P, Di Tucci C, D’oria O, et al: Prevention of recurrent lower urinary tract infections in postmenopausal women with genitourinary syndrome: outcome after 6 months of treatment with ospemifene. Gynecol Endocrinol 2017; 1–4.
49.
Domenici L, Monti M, Bracchi C, Giorgini M, Colagiovanni V, Muzii L, et al: D-mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur Rev Med Pharmacol Sci 2016; 20: 2920–2925.
50.
Price TK, Dune T, Hilt EE, Thomas-White KJ, Kliethermes S, Brincat C, et al: The clinical urine culture: enhanced techniques improve detection of clinically relevant microorganisms. J Clin Microbiol 2016; 54: 1216–1222.
51.
Chang SJ, Lin CD, Hsieh CH, Liu YB, Chiang IN, Yang SS: Reliability and validity of a Chinese version of urinary tract infection symptom assessment questionnaire. Int Braz J Urol 2015; 41: 729–738.
52.
Wild DJ, Clayson DJ, Keating K, Gondek K: Validation of a patient-administered questionnaire to measure the activity impairment experienced by women with uncomplicated urinary tract infection: the Activity Impairment Assessment (AIA). Health Qual Life Outcomes 2005; 3: 42.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.